Reported Consolidated quarterly numbers for Sun Pharma Advanced Research Company are:
Net Sales at Rs 9.64 crore in June 2025 down 42.65% from Rs. 16.81 crore in June 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 51.87 crore in June 2025 up 45.91% from Rs. 95.90 crore in June 2024.
EBITDA stands negative at Rs. 42.94 crore in June 2025 up 53.22% from Rs. 91.80 crore in June 2024.
Sun Pharma Adv shares closed at 142.41 on August 08, 2025 (NSE) and has given -4.98% returns over the last 6 months and -33.81% over the last 12 months.
Story continues below Advertisement
| Sun Pharma Advanced Research Company | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Jun'25 | Mar'25 | Jun'24 | | Net Sales/Income from operations | 9.64 | 27.19 | 16.81 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 9.64 | 27.19 | 16.81 | | EXPENDITURE | | Consumption of Raw Materials | 5.13 | 5.70 | 4.53 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 31.32 | 29.85 | 54.26 | | Depreciation | 2.68 | 2.95 | 3.14 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 25.27 | 44.82 | 51.38 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -54.76 | -56.13 | -96.50 | | Other Income | 9.14 | -- | 1.56 | | P/L Before Int., Excpt. Items & Tax | -45.62 | -56.13 | -94.94 | | Interest | 6.19 | 4.54 | 0.56 | | P/L Before Exceptional Items & Tax | -51.81 | -60.67 | -95.50 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -51.81 | -60.67 | -95.50 | | Tax | 0.06 | -0.90 | 0.40 | | P/L After Tax from Ordinary Activities | -51.87 | -59.77 | -95.90 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -51.87 | -59.77 | -95.90 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -51.87 | -59.77 | -95.90 | | Equity Share Capital | 32.45 | 32.45 | 32.45 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -1.60 | -1.84 | -2.96 | | Diluted EPS | -1.60 | -1.84 | -2.96 | | EPS After Extra Ordinary | | Basic EPS | -1.60 | -1.84 | -2.96 | | Diluted EPS | -1.60 | -1.84 | -2.96 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
